The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis

OBJECTIVES: Anticoagulants have been used as therapeutic or prophylactic agents in COVID-19 and seem to be more beneficial. However, the advantage of oral anticoagulant (OAC) consumption before visit in lowering mortality in COVID-19 patients remains debatable. This meta-analysis aimed to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghea, Cornelia, Wardhana, Ardyan, Nugroho, Alfredo, Assilmi, Fika Humaeda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399847/
https://www.ncbi.nlm.nih.gov/pubmed/37545792
http://dx.doi.org/10.4103/tcmj.tcmj_199_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399847/
https://www.ncbi.nlm.nih.gov/pubmed/37545792
http://dx.doi.org/10.4103/tcmj.tcmj_199_22

Ejemplares similares